FIELD: medicine.
SUBSTANCE: claimed is method of differential diagnostics of malignant tumour and myoma of endometrium. In material of patient's uterus tumour, obtained during operation, content of zinc and level of metalloprotease (MMP) expression are determined. If amount of zinc in tumour tissue increases from 105 to 160 ppm and MMP expression 3.9 is present, prognosis about presence of malignant tumour with tendency to metastases is made, if zinc amount decreases from 153 to 75 ppm in tumour tissue in comparison with non-transformed and MMP expression 2 is present, conclusion about uterus myoma is made.
EFFECT: increase of prediction accuracy.
1 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIAGNOSING BREAST CANCER AND OVARIAN CANCER BY MMP-9 MRNA LEVEL IN BLOOD PLASMA | 2020 |
|
RU2745424C1 |
| METHOD FOR PREDICTION OF THE PATHOLOGICAL PROCESS IN UTERINE BODY CANCER | 2019 |
|
RU2712307C1 |
| TEST-SYSTEM FOR PREDICTION OF RELAPSE DEVELOPMENT IN PATIENTS WITH UTERINE CORPUS CANCER BASED ON EXPRESSION LEVEL OF THE ESR1 GENE | 2017 |
|
RU2661599C1 |
| METHOD FOR PREDICTION OF ENDOMETRIAL CANCER PATIENTS SURVIVAL ON THE BASIS OF THE ESR1 GENE EXPRESSION LEVEL | 2015 |
|
RU2611352C1 |
| DIAGNOSTIC TECHNIQUE FOR BREAST CANCER | 2013 |
|
RU2547583C2 |
| METHOD OF RECURRENT ENDOMETRIAL CANCER PREDICTION BASED ON PTEN AND CYP1B1 GENES EXPRESSION LEVEL | 2015 |
|
RU2605302C1 |
| METHOD FOR PREDICTION OF DEVELOPING METASTASES IN UTERINE CANCER PATIENTS BASED ON ANALYSIS OF MAGEA1, MAGEB2 AND PRAME1 GENE EXPRESSION | 2018 |
|
RU2698895C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR INDIVIDUAL'S THYROID NEW GROWTHS | 2014 |
|
RU2569154C1 |
| METHOD OF PREDICTING DEVELOPMENT OF RISK OF COMBINED PROLIFERATIVE REPRODUCTIVE SYSTEM DISEASES IN WOMEN | 2014 |
|
RU2557954C1 |
| METHOD OF PREDICTING DEVELOPMENT OF METACHRONOUS HYPERPLASTIC PROCESSES IN ORGANS OF FEMALE REPRODUCTIVE SYSTEM | 2010 |
|
RU2436517C1 |
